Zalewska-Szewczyk B - Search Results

1

Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.

Braun M, Pastorczak A, Fendler W, Madzio J, Tomasik B, Taha J, Bielska M, Sedek L, Szczepanski T, Matysiak M, Derwich K, Lejman M, Kowalczyk J, Kazanowska B, Badowska W, Styczynski J, Irga-Jaworska N, Trelinska J, Zalewska-Szewczyk B, Pierlejewski F, Wlodarska I, Młynarski W; Polish Pediatric Leukemia/Lymphoma Study Group. Braun M, et al. Leuk Lymphoma. 2017 May;58(5):1162-1171. doi: 10.1080/10428194.2016.1228925. Epub 2016 Oct 18. Leuk Lymphoma. 2017. PMID: 27756164

2

Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.

Zalewska-Szewczyk B, Andrzejewski W, Bodalski J. Zalewska-Szewczyk B, et al. Pediatr Blood Cancer. 2004 Oct;43(5):600-2. doi: 10.1002/pbc.20064. Pediatr Blood Cancer. 2004. PMID: 15382279

3

Cytoprotective effect of amifostine in the treatment of childhood neoplastic diseases--a clinical study including the pharmacoeconomic analysis.

Stolarska M, Mlynarski W, Zalewska-Szewczyk B, Bodalski J. Stolarska M, et al. Pharmacol Rep. 2006 Jan-Feb;58(1):30-4. Pharmacol Rep. 2006. PMID: 16531627 Free article.

4

The anti-asparagines antibodies correlate with L-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia.

Zalewska-Szewczyk B, Andrzejewski W, Młynarski W, Jedrychowska-Dańska K, Witas H, Bodalski J. Zalewska-Szewczyk B, et al. Leuk Lymphoma. 2007 May;48(5):931-6. doi: 10.1080/10428190701292049. Leuk Lymphoma. 2007. PMID: 17487737

5

[Acute lymphoblastic leukemia in a child with Sturge-Weber syndrome--case report].

Brodowska B, Trelińska J, Zalewska-Szewczyk B, Bodalski J. Brodowska B, et al. Pol Merkur Lekarski. 2007 Sep;23(135):206-8. Pol Merkur Lekarski. 2007. PMID: 18080696 Polish.

6

The cross-reactivity of anti-asparaginase antibodies against different L-asparaginase preparations.

Zalewska-Szewczyk B, Gach A, Wyka K, Bodalski J, Młynarski W. Zalewska-Szewczyk B, et al. Clin Exp Med. 2009 Jun;9(2):113-6. doi: 10.1007/s10238-008-0026-9. Epub 2009 Jan 30. Clin Exp Med. 2009. PMID: 19184328

7

[Changes in the lipid profile in children with acute lymphoblastic leukaemia - the influence of the disease and its treatment].

Zalewska-Szewczyk B, Matusiak I, Wyka K, Trelińska J, Stolarska M, Młynarski W. Zalewska-Szewczyk B, et al. Med Wieku Rozwoj. 2008 Oct-Dec;12(4 Pt 2):1035-40. Med Wieku Rozwoj. 2008. PMID: 19531822 Polish.

8

Asparagine synthetase (ASNS) gene polymorphism is associated with the outcome of childhood acute lymphoblastic leukemia by affecting early response to treatment.

Pastorczak A, Fendler W, Zalewska-Szewczyk B, Górniak P, Lejman M, Trelińska J, Walenciak J, Kowalczyk J, Szczepanski T, Mlynarski W; Polish Pediatric Leukemia/Lymphoma Study Group. Pastorczak A, et al. Leuk Res. 2014 Feb;38(2):180-3. doi: 10.1016/j.leukres.2013.10.027. Epub 2013 Nov 5. Leuk Res. 2014. PMID: 24268318

9

Interleukin 18 as a marker of chronic nephropathy in children after anticancer treatment.

Zubowska M, Wyka K, Fendler W, Młynarski W, Zalewska-Szewczyk B. Zubowska M, et al. Dis Markers. 2013;35(6):811-8. doi: 10.1155/2013/369784. Epub 2013 Nov 27. Dis Markers. 2013. PMID: 24379519 Free PMC article.

10

Anaphylactic reaction to polyethylene glycol-conjugated asparaginase: premedication and desensitization may not be sufficient.

Walenciak J, Mlynarski W, Zalewska-Szewczyk B. Walenciak J, et al. Pediatr Int. 2014 Feb;56(1):130-1. doi: 10.1111/ped.12270. Pediatr Int. 2014. PMID: 24548205 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters